MedWatch

Lundbeck to delist in US

The pharmaceutical firm’s new share structure means that Lundbeck is terminating its trading program in the US.

Photo: Michael M. Santiago/AFP / GETTY IMAGES NORTH AMERICA

US investors will soon be unable to trade Lundbeck shares in their own currency and during US stock exchange opening hours.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs